It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The discovery of upstream regulatory genes of a gene of interest still remains challenging. Here we applied a scalable computational method to unbiasedly predict candidate regulatory genes of critical transcription factors by searching the whole genome. We illustrated our approach with a case study on the master regulator FOXP3 of human primary regulatory T cells (Tregs). While target genes of FOXP3 have been identified, its upstream regulatory machinery still remains elusive. Our methodology selected five top-ranked candidates that were tested via proof-of-concept experiments. Following knockdown, three out of five candidates showed significant effects on the mRNA expression of FOXP3 across multiple donors. This provides insights into the regulatory mechanisms modulating FOXP3 transcriptional expression in Tregs. Overall, at the genome level this represents a high level of accuracy in predicting upstream regulatory genes of key genes of interest.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details





1 University of Luxembourg, Luxembourg Centre for Systems Biomedicine, Belvaux, Luxembourg (GRID:grid.16008.3f) (ISNI:0000 0001 2295 9843)
2 University of Luxembourg, Luxembourg Centre for Systems Biomedicine, Belvaux, Luxembourg (GRID:grid.16008.3f) (ISNI:0000 0001 2295 9843); Luleå University of Technology, Robotics and Artificial Intelligence, Department of Computer Science, Electrical and Space Engineering, Luleå, Sweden (GRID:grid.6926.b) (ISNI:0000 0001 1014 8699)
3 Luxembourg Institute of Health, Department of Infection and Immunity, Esch-Sur-Alzette, Luxembourg (GRID:grid.451012.3) (ISNI:0000 0004 0621 531X); University of Luxembourg, Faculty of Science, Technology and Medicine, Esch-sur-Alzette, Luxembourg (GRID:grid.16008.3f) (ISNI:0000 0001 2295 9843)
4 Luxembourg Institute of Health, Department of Infection and Immunity, Esch-Sur-Alzette, Luxembourg (GRID:grid.451012.3) (ISNI:0000 0004 0621 531X); University of Luxembourg, Faculty of Science, Technology and Medicine, Esch-sur-Alzette, Luxembourg (GRID:grid.16008.3f) (ISNI:0000 0001 2295 9843); Luxembourg Institute of Health, Transversal Translational Medicine, Strassen, Luxembourg (GRID:grid.451012.3) (ISNI:0000 0004 0621 531X)
5 Luxembourg Institute of Health, Department of Infection and Immunity, Esch-Sur-Alzette, Luxembourg (GRID:grid.451012.3) (ISNI:0000 0004 0621 531X)
6 Huazhong University of Science and Technology, School of Artificial Intelligence and Automation, Wuhan, China (GRID:grid.33199.31) (ISNI:0000 0004 0368 7223)
7 University of Luxembourg, Luxembourg Centre for Systems Biomedicine, Belvaux, Luxembourg (GRID:grid.16008.3f) (ISNI:0000 0001 2295 9843); University of Cambridge, Department of Plant Sciences, Cambridge, United Kingdom (GRID:grid.5335.0) (ISNI:0000 0001 2188 5934)